What's new

Human medicines European public assessment report (EPAR): Kavigale, sipavibart, Date of authorisation: 20/01/2025, Status: Authorised

Human medicines European public assessment report (EPAR): Kavigale, sipavibart, Date of authorisation: 20/01/2025, Status: Authorised

Feb 24, 2025 - 17:07
 0
Human medicines European public assessment report (EPAR): Kavigale, sipavibart, Date of authorisation: 20/01/2025, Status: Authorised
Human medicines European public assessment report (EPAR): Kavigale, sipavibart, Date of authorisation: 20/01/2025, Status: Authorised
Read More

Tags:

Previous Article

Liver transplant specialist OrganOx raises $142M for tissue support system

Next Article

Are utility demand response program costs outstripping their benefits in Califor...

Related Posts

Agenda of the COMP meeting 3-5 December 2024

Feb 21, 2025  0

Human medicines European public assessment report (EPAR): Trydonis, beclometasone,formoterol,glycopyrronium bromide, Date of authorisation: 26/04/2018, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 17, 2025  0

Good manufacturing practice

Good manufacturing practice

Feb 24, 2025  0